Gaëlle Guillerm

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau et al. · Blood · 2007 · 905 citations · Full text

Medicine, Genetics, Hematology +15

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

Thierry Façon, Jean Yves Mary, Cyrille Hulin et al. · The Lancet · 2007 · 870 citations

Medicine, Hematology, Oncology +17

Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial

Cyrille Hulin, Thierry Façon, Philippe Rodon et al. · Journal of Clinical Oncology · 2009 · 381 citations

Medicine, Pharmacology, Pharmacotherapy +17

Methylation of the p15INK4b Gene in Myelodysplastic Syndromes Is Frequent and Acquired During Disease Progression

Bruno Quesnel, Gaëlle Guillerm, Rodolphe Vereecque et al. · Blood · 1998 · 346 citations

Life Sciences, Genetics, Molecular Genetics +12

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Delphine Réa, Franck E. Nicolini, Michel Tulliez et al. · Blood · 2016 · 317 citations · Full text

Medicine, Hematology, Oncology +8